Hermetica Superfood Encyclopedia
The Short Answer
Zagalanda contains eugenol (up to 76.01% of essential oil), rosmarinic acid, luteolin, and apigenin, which exert antipyretic and anti-inflammatory effects primarily through NF-κB pathway inhibition, pro-inflammatory cytokine downregulation (TNF-α, IL-6), and free radical scavenging. Preclinical in vitro and animal studies support its antimicrobial, antioxidant, antidiabetic, and hepatoprotective activities, though no controlled human clinical trials have yet quantified effect sizes for fever reduction or other endpoints.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordZagalanda benefits
Zagalanda — botanical close-up
Health Benefits
**Fever Reduction (Antipyretic)**
Leaf decoctions and infusions have been used traditionally across West Africa to reduce fever; flavonoids such as luteolin and rosmarinic acid are believed to suppress prostaglandin-mediated pyrexia through COX pathway modulation, though human trials confirming specific antipyretic effect sizes are lacking.
**Antimicrobial Activity**
Eugenol and thymol present in the essential oil disrupt bacterial and fungal cell membranes through lipid solubility-mediated permeability changes; in vitro endophyte-derived metabolites from O. gratissimum demonstrated antibacterial inhibition zones of 12.66 ± 0.33 mm at 100% concentration against clinical isolates.
**Antioxidant Protection**
Rosmarinic acid, caffeic acid, epicatechin, and vicenin-2 scavenge reactive oxygen species and inhibit lipid peroxidation, modulating antioxidant enzymes including superoxide dismutase; these effects have been demonstrated in cell-based assays, though activity was noted to be lower than vitamin C reference controls.
**Anti-Inflammatory Effects**
Polyphenols including luteolin and apigenin downregulate pro-inflammatory cytokines TNF-α and IL-6 and inhibit the NF-κB signaling pathway; these mechanisms collectively contribute to the plant's traditional use in treating inflammatory conditions such as skin infections and respiratory ailments.
**Antidiabetic Potential**
Phenolic compounds in leaf extracts inhibit α-glucosidase activity, slowing postprandial glucose absorption; animal model studies have reported blood glucose-lowering effects, positioning this herb as a candidate for adjunctive management of type 2 diabetes pending clinical validation.
**Hepatoprotective Effects**
In vivo studies using rodent models suggest that O. gratissimum extracts mitigate hepatotoxin-induced liver damage, likely through antioxidant mechanisms involving oleanolic acid and rosmarinic acid; these findings remain preclinical and require replication in human subjects.
**Antihypertensive and Vasorelaxant Properties**
Vasorelaxant activity has been attributed to nitric oxide modulation and calcium channel antagonism by flavonoid constituents; animal studies demonstrate reductions in blood pressure parameters, supporting traditional use for cardiovascular complaints but awaiting clinical translation.
Origin & History
Natural habitat
Ocimum gratissimum, commonly called African basil or clove basil, is native to tropical and subtropical regions of Africa and Asia, with particularly widespread distribution across West Africa, including Nigeria, Ghana, and Cameroon. The plant thrives in disturbed habitats, roadsides, and cultivated gardens at low to mid elevations, tolerating a range of soil types but preferring well-drained, loamy soils with high organic matter content. In northern Nigeria, it is known locally as Zagalanda and has been cultivated and harvested from wild populations for centuries as part of traditional Hausa and broader West African ethnomedicine.
“Ocimum gratissimum has been integrated into West, Central, and East African traditional medicine systems for at least several centuries, with documented use in Nigeria, Ghana, Benin, Cameroon, and across into South and Southeast Asian ethnomedicine traditions. In northern Nigeria, where it is called Zagalanda by Hausa-speaking communities, the plant is a primary herbal remedy for febrile illness, wound infections, respiratory tract infections, and gastrointestinal complaints, often prepared as a hot leaf decoction administered to children and adults alike. Beyond medicinal use, leaves are used as a culinary spice in various African cuisines and as a fumigant and insect repellent, reflecting its broad cultural utility. Historical documentation in Nigerian ethnobotanical surveys and African pharmacopoeia compilations consistently records this species among the most commonly used medicinal herbs across sub-Saharan Africa, underscoring its deep cultural entrenchment despite limited formal clinical investigation.”Traditional Medicine
Scientific Research
The evidence base for Zagalanda (Ocimum gratissimum) consists almost entirely of in vitro cell culture experiments and in vivo animal model studies, with no published randomized controlled human clinical trials identified at this time. In vitro studies have documented antimicrobial inhibition zones of 12.66 ± 0.33 mm against clinical bacterial isolates using endophyte-derived metabolites at 100% concentration, and antioxidant assays have confirmed radical scavenging activity, though at lower potency than ascorbic acid reference standards. Animal studies have reported antidiabetic, hepatoprotective, antihypertensive, and anti-inflammatory outcomes using rodent models, but quantitative effect sizes and interspecies extrapolation to human therapeutic doses remain unestablished. The absence of standardized extract preparations, dose-ranging clinical pharmacology data, and Phase I/II human safety and efficacy trials represents a significant gap, placing this ingredient firmly in the preclinical evidence category despite centuries of traditional use.
Preparation & Dosage
Traditional preparation
**Traditional Leaf Decoction (Tea)**
20–30 g of fresh leaves or 5–10 g of dried leaves boiled in 500 mL water for 10–15 minutes; consumed 1–2 times daily for fever and infections in West African traditional practice — no clinically validated dose established
Approximately .
**Leaf Infusion**
Dried or fresh leaves steeped in hot water (not boiled) for 10 minutes; used similarly to decoction with a milder flavor profile and potentially reduced volatile oil content due to lower temperatures.
**Essential Oil (Topical)**
Steam-distilled oil applied topically at 1–5% dilution in a carrier oil for antimicrobial and anti-inflammatory skin applications; undiluted use is not recommended due to mucosal irritancy potential of eugenol.
**Crude Hydroalcoholic Extract**
Methanol or ethanol extracts used in laboratory studies; no commercially standardized extract with defined eugenol or rosmarinic acid percentage is currently available for consumer supplementation.
**Ethyl Acetate Extract (Research Grade)**
Used in phenolic compound isolation studies; not a consumer product form but represents the extraction method yielding highest flavonoid concentration in published analyses.
**Timing Note**
Traditional fever-reduction preparations are typically administered at onset of fever and repeated every 4–6 hours; optimal clinical timing has not been established through pharmacokinetic study.
Nutritional Profile
Fresh Ocimum gratissimum leaves provide modest macronutrient content typical of leafy herbs, with protein, carbohydrates, and dietary fiber contributing nutritional value in culinary quantities. Micronutrients include zinc, which is associated with zinc-binding proteins involved in enzyme regulation, as well as calcium, potassium, and iron at concentrations consistent with other Ocimum species. Phytochemically, the most abundant bioactive constituents are eugenol (up to 76.01% of essential oil by GC analysis), rosmarinic acid, caffeic acid, sinapic acid, oleanolic acid, epicatechin, luteolin, apigenin, thymol, geraniol, β-caryophyllene, 1,8-cineole, and linalool, with concentrations varying substantially by geographic origin, plant part, harvesting season, and extraction method. Bioavailability is compound-dependent: lipophilic terpenoids such as eugenol and β-caryophyllene are expected to have enhanced absorption with fatty meals, while polar phenolics like rosmarinic acid undergo intestinal and hepatic phase II metabolism, and precise human bioavailability data for this species have not been published.
How It Works
Mechanism of Action
Eugenol, the dominant essential oil constituent (up to 76.01% of oil composition), disrupts microbial plasma membranes by integrating into phospholipid bilayers and inhibiting membrane-bound ATPases, while also inhibiting cyclooxygenase enzymes to reduce prostaglandin synthesis relevant to fever and pain. Rosmarinic acid and luteolin suppress the NF-κB transcription pathway by blocking IκB kinase phosphorylation, thereby reducing downstream transcription of TNF-α, IL-6, and IL-1β, which underpins the plant's anti-inflammatory and antipyretic actions. Flavonoids such as apigenin and epicatechin chelate transition metals and donate hydrogen atoms to neutralize reactive oxygen species, while simultaneously upregulating endogenous antioxidant enzyme expression including superoxide dismutase and catalase. Alpha-glucosidase inhibition by phenolic acids including caffeic acid and sinapic acid competitively slows intestinal carbohydrate digestion, reducing glycemic excursions, and vasorelaxant effects are mediated through endothelial nitric oxide synthase activation and L-type calcium channel modulation by terpenoid fractions.
Clinical Evidence
No controlled human clinical trials have been conducted on Zagalanda (Ocimum gratissimum) for any indication including its primary traditional use of fever reduction. Available preclinical data derives from in vitro antibacterial, antifungal, antioxidant, and cytotoxicity assays, as well as rodent models for diabetes, hypertension, hepatotoxicity, and inflammation, none of which provide direct evidence of clinical efficacy or safe dosing ranges in humans. Effect sizes reported in animal studies, such as blood glucose reduction and liver enzyme normalization, are promising but cannot be directly extrapolated to human therapeutic outcomes without pharmacokinetic and toxicological bridging studies. Confidence in clinical application remains low; the ingredient warrants Phase I safety trials followed by properly powered efficacy studies before evidence-based supplementation recommendations can be formulated.
Safety & Interactions
Formal toxicological and clinical safety data for Zagalanda (Ocimum gratissimum) in humans are absent from the published literature, and no established maximum safe dose, no-observed-adverse-effect level (NOAEL), or tolerable upper intake level has been determined for any extract form or preparation. The high eugenol content of the essential oil presents a plausible mucosal irritancy and hepatotoxicity risk at suprapharmacological doses, as eugenol is a known contact sensitizer and hepatotoxin in isolated hepatocytes at elevated concentrations; essential oils should not be consumed undiluted. Potential pharmacokinetic interactions with anticoagulant medications (e.g., warfarin) are biologically plausible given eugenol's platelet aggregation-inhibiting properties, and co-administration with antidiabetic drugs carries theoretical additive hypoglycemic risk based on animal model α-glucosidase inhibition data; however, these interactions have not been confirmed in human subjects. Use during pregnancy and lactation is not supported by safety data and should be avoided given the potential uterotonic effects associated with high-eugenol essential oils; individuals with liver disease or clotting disorders should exercise particular caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ocimum gratissimumAfrican basilClove basilScent leafEffirin (Yoruba)Nchuanwu (Igbo)Tree basilWild basil
Frequently Asked Questions
What is Zagalanda used for in traditional African medicine?
Zagalanda (Ocimum gratissimum) is used primarily in northern Nigerian and broader West African traditional medicine for reducing fever, treating bacterial and fungal infections, managing gastrointestinal complaints such as diarrhea, and alleviating respiratory tract symptoms. Preparations typically consist of hot leaf decoctions consumed orally or applied as poultices, with the high eugenol and rosmarinic acid content of the plant believed to underlie its antimicrobial and anti-inflammatory activities. It is also used in some communities as a culinary spice and household insect repellent.
What are the key active compounds in Ocimum gratissimum?
The most pharmacologically significant compounds in Ocimum gratissimum are eugenol, which constitutes up to 76.01% of the essential oil and drives antimicrobial and anti-inflammatory activity, along with rosmarinic acid, caffeic acid, sinapic acid, and oleanolic acid in the phenolic fraction. Flavonoids including luteolin, apigenin, and epicatechin contribute to antioxidant and anti-inflammatory effects through NF-κB pathway inhibition and free radical scavenging. Additional sesquiterpenes such as β-caryophyllene and geraniol, along with monoterpenes thymol and 1,8-cineole, contribute to the essential oil's broad antimicrobial spectrum.
Is there clinical trial evidence supporting the use of Zagalanda for fever?
No randomized controlled human clinical trials have been published evaluating Zagalanda or Ocimum gratissimum for fever reduction or any other clinical indication as of current literature. Available evidence is limited to in vitro cell studies and in vivo animal experiments demonstrating anti-inflammatory, antimicrobial, and antioxidant effects, which provide a mechanistic rationale for its traditional antipyretic use but do not constitute clinical proof of efficacy or safety in humans. Prospective clinical trials are needed before evidence-based dosing recommendations can be established.
Are there any safety concerns or drug interactions with Zagalanda?
Formal human safety data for Zagalanda are absent, and no established safe dosage range has been determined through clinical study. The high eugenol content of the essential oil poses a theoretical risk of mucosal irritation and, at very high doses, hepatotoxicity, and individuals taking anticoagulants such as warfarin should exercise caution due to eugenol's platelet aggregation-inhibiting properties. Pregnant and lactating women are advised to avoid concentrated preparations or essential oil forms, as high-eugenol botanicals have potential uterotonic activity, though evidence specific to O. gratissimum in humans is lacking.
How is Zagalanda prepared and what is the typical dose?
Traditionally, Zagalanda is prepared as a leaf decoction using approximately 20–30 g of fresh leaves or 5–10 g of dried leaves simmered in 500 mL of water for 10–15 minutes and consumed one to two times daily. The essential oil is steam-distilled for topical antimicrobial applications and should be diluted to 1–5% in a carrier oil before skin application to avoid eugenol-mediated irritation. No standardized extract product with defined phytochemical concentrations is currently available commercially, and no clinically validated dose for any indication has been established through controlled human trials.
What is the most effective form of Zagalanda for antimicrobial benefits—fresh leaf, dried leaf, or essential oil?
Dried leaf decoctions and infusions are the most traditional and studied forms for antimicrobial activity, as they preserve eugenol and thymol content while being safe for internal use. Essential oil is highly concentrated and antimicrobially potent but requires careful dilution and should not be ingested directly without professional guidance. Fresh leaf preparations are less stable and lose volatile compounds more rapidly than dried forms, making them less reliable for consistent antimicrobial effects.
Is Zagalanda safe for children, and if so, what age group can use it?
Traditional use in West African communities includes application to children with fever, but formal safety data for specific pediatric age groups is limited. Children over 5 years old may tolerate mild leaf infusions in reduced doses under practitioner supervision, but infants and very young children should avoid supplementation without clear medical guidance. Parents should consult a healthcare provider before giving any Zagalanda preparation to children.
How does Zagalanda's antimicrobial mechanism compare to other traditional fever herbs like African ginger or neem?
Zagalanda's antimicrobial action is primarily driven by eugenol and thymol targeting bacterial cell membranes, whereas African ginger relies more on gingerol compounds and neem uses azadirachtin for broader parasitic and microbial effects. Zagalanda is traditionally regarded as gentler on the stomach than neem, making it more suitable for sensitive individuals, while ginger offers additional anti-inflammatory benefits. The three herbs are often used complementarily in traditional African medicine rather than as direct substitutes.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w zagalanda-ocimum-gratissimum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
